Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trial
ISRCTN ISRCTN27307877
ClinicalTrials.gov identifier
Public title Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trial
Scientific title
Acronym N/A
Serial number at source N0158153706
Study hypothesis To compare the effectiveness of 46.7% trisodium citrate versus unfractionated heparin (5000 IU/ml) in preventing clotting of tunnelled haemodialysis catheters.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Renal failure
Participants - inclusion criteria Any patient who require a new tunnelled catheter for haemodialysis. Patients fall into three groups:
1. Patients who present to the Kidney unit of the UHNS with kidney failure needing maintenance haemodialysis
2. Patients who have to switch from peritoneal to haemodialysis because of problems with their peritoneal dialysis
3. Existing haemodialysis patients who need tunnelled catheters because their arterivenous fistulas or tunnelled catheters have failed
The decision to place a tunnelled dialysis catheter is made by one of the renal consultants entirely on the basis of clinical need. Patients will be invited to take part prior to insertion of the tunnelled dialysis catheter. Randomisation will be by sealed envelopes. The only differences in dialysis care that patients will have is the locking agent, otherwise patients will have the same treatment whether they are dialysing in our main renal unit in Stoke or our two satellite units at Stafford and Leighton. They will be followed up and all dialysis related issues will be documented as per current practice.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/02/2005
Anticipated end date 01/08/2006
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters.
Primary outcome measure(s) Catheter blood flow of less than 250 ml/minute and/or venous pressure of more than 260 mmHG, persisting for one hour/session, in two consecutive sessions.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding North Staffordshire Research and Development Consortium (UK)
Trial website
Publications
Contact name Dr  M  Abdalla
  Address Nephrology Department
North Staffordshire Royal Infirmary
Princes Road
Hartshill
  City/town Stoke-on-Trent
  Zip/Postcode ST4 7LN
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 07/09/2011
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central